Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) Assets Average (2016 - 2025)

Historic Assets Average for AC Immune (ACIU) over the last 9 years, with Q3 2025 value amounting to $222.1 million.

  • AC Immune's Assets Average fell 1841.54% to $222.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.1 million, marking a year-over-year decrease of 1841.54%. This contributed to the annual value of $234.8 million for FY2024, which is 1712.58% up from last year.
  • Per AC Immune's latest filing, its Assets Average stood at $222.1 million for Q3 2025, which was down 1841.54% from $232.3 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Assets Average registered a high of $272.8 million during Q4 2024, and its lowest value of $226507.9 during Q3 2021.
  • Over the past 5 years, AC Immune's median Assets Average value was $202.9 million (recorded in 2022), while the average stood at $189.4 million.
  • In the last 5 years, AC Immune's Assets Average plummeted by 9991.94% in 2021 and then surged by 9917258.18% in 2022.
  • Over the past 5 years, AC Immune's Assets Average (Quarter) stood at $141.9 million in 2021, then surged by 43.03% to $202.9 million in 2022, then decreased by 9.33% to $184.0 million in 2023, then skyrocketed by 48.24% to $272.8 million in 2024, then fell by 18.55% to $222.1 million in 2025.
  • Its Assets Average was $222.1 million in Q3 2025, compared to $232.3 million in Q2 2025 and $249.2 million in Q1 2025.